Skip to main content

Table 3 Laboratory scale cranberry fraction FC111 constituents separated and characterized by HPLC-DAD-MS.

From: In vitro and in vivo antibacterial activities of cranberry press cake extracts alone or in combination with β-lactams against Staphylococcus aureus

Peak

tR(min)a

λmax (nm)b

MW (Da)c

Putative identification

Relative abundanced

1a,b

4.8

 

192

quinic acid

 

Iridoids

  

2a,b

6.5

235

390

monotropein

18.5 ± 0.78%

3

7.3

235

392

6,7-dihydromonotropein

26.8 ± 0.07%

16b

14.4

235

416

unknown monotropein derivative

54.8 ± 0.99%

    

Total (vs. A254 nm)

22 %

Monophenolic acids

4

8.7

280

220

unknown benzoic acid derivative

3.1 ± 0.51%

5

8.9

280

 

unknown benzoic acid derivative

0.52 ± 0.06%

6

9.7

290

162

unknown benzoic acid derivative

0.78 ± 0.10%

7

9.8

290

 

unknown benzoic acid derivative

1.18 ± 0.11%

8

10.4

275

316

dihydroxybenzoic acid glycoside

3.45 ± 0.29%

9a,b

11.6

285, 320

342

caffeic acid glycoside

3.06 ± 0.45%

10

12.0

275

300

hydroxybenzoic acid glycoside

0.72 ± 0.16%

11

12.3

295, 305

326

coumaric acid glycoside isomer 1

14.04 ± 0.49%

12

12.4

275

238

unknown benzoic acid derivative

1.45 ± 0.049%

13

13.6

315

326

coumaric acid glycoside isomer 2

15.1 ± 0.40%

14

13.8

285, 310

326

coumaric acid glycoside isomer 3

16.1 ± 0.56%

15

14.1

295, 325

 

unknown hydroxycinnamic acid

7.22 ± 0.092%

16a

14.4

280

284

benzoyl-glycoside

5.44 ± 0.89%

17

14.7

285, 330

356

ferulic acid-glycoside

5.59 ± 0.21%

18

15.0

275

 

unknown benzoic acid derivative

13.24 ± 0.13%

19

15.3

280, 330

386

sinapinic acid-glycoside

7.47 ± 0.28%

20a,b

16.3

280

 

unknown benzoic acid derivative

1.50 ± 0.69%

    

Total (vs. A254 nm)

9%

Anthocyanins

21

16.8

525

465

delphinidin-3-O-galactoside

0.40 ± 0.00%

24

18.0

518

449

cyanidin-3-O-galactoside

18.4 ± 0.01%

25

18.2

525

435

delphinidin-3-O-arabinoside

0.60 ± 0.03%

26

19.0

515

433

pelargonidin-3-O-galactoside

0.28 ± 0.00%

27

19.3

520

419

cyanidin-3-O-arabinoside

11.2 ± 0.00%

28

19.8

520

463

peonidin-3-O-galactoside

43.3 ± 0.03%

29

20.4

524

493

malvidin-3-O-galactoside

7.64 ± 0.00%

31

21.1

521

433

peonidin-3-O-arabinoside

15.5 ± 0.01%

33

21.6

530

463

malvidin-3-O-arabinoside

1.79 ± 0.00%

    

Total (vs. A254 nm)

40%

Flavonols

30

20.5

370

450

myricetin-3-O-arabinoside

4.05 ± 0.34%

32

21.3

360

464

quercetin-3-O-galactoside

50.2 ± 0.11%

34

22.0

354

434

quercetin-3-O-xyloside

7.71 ± 0.00%

35

22.3

352

434

quercetin-3-O-arabinopyranoside

3.72 ± 0.02%

36

22.8

354

434

quercetin-3-O-arabinofuranside

13.65 ± 0.12%

37

23.3

352

448

quercetin-3-O-rhamnoside

2.87 ± 0.01%

38

23.6

356

478

isorhamnetin-3-O-galactoside

5.31 ± 0.04%

39

24.0

360

508

syringetin-3-O-galactoside

4.70 ± 0.05%

40

24.7

360

 

unknown flavonol derivative

0.46 ± 0.02%

41

25.0

355

448

isorhamnetin-3-O-arabinoside

1.55 ± 0.01%

42a,b

25.6

355

610

quercetin-3-O-(6”coumaroyl)-galactoside

2.27 ± 0.04%

43

26.1

355

478

syringetin-3-O-arabinoside

2.04 ± 0.04%

44

27.5

356

568

quercetin-3-O-(6” benzoyl)-galactoside

1.48 ± 0.02%

    

Total (vs. A254 nm)

25%

  1. a tR , retention time of peak (measured in minutes).
  2. b λmax, refers to characteristic UV–VIS absorption maxima (nm) pertinent to identification.
  3. c MW, molecular weight (measured in Daltons).
  4. d Relative abundance reported as percentage with associated standard deviation (based on two separate HPLC runs); iridoids calculated vs. 254 nm; monophenolic acids calculated vs. 280 nm; anthocyanins calculated vs. 520 nm; flavonols calculated vs. 360 nm.